Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

NCT05738382 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Assisted Reproductive Technology
Controlled Ovarian Hyperstimulation

Interventions

DRUG: BG2109
DRUG: Cetrorelix

Sponsor

Bio Genuine (Shanghai) Biotech Co., Ltd.